By recognizing the limitations of today’s production processes, the industry may be able to overcome the challenges, complexity, and high cost of manufacturing vaccines and viral vector-based therapies.

Biopharmaceutical executives must consider how outsourcing fits into their development and production strategy, as well as how to select the best CDMO partner for their business. Here’s a step-by-step guide to help make that decision.

3D printing allows drug companies to not only boost efficacy and adherence but also contribute to their brand longevity by expanding and capturing market share with other dosage form options. 

This study shows a process for scaling up Vero cell culture from static T-flasks and Thermo Scientific Nunc Cell Factory Systems to a stirred-tank system.

GE Healthcare Life Sciences

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.